Pomegranate peel methanol extract exhibits cholinesterase inhibitory activity in vitro [295] and in vivo, suggesting its potential role in the prevention and co-treatment of Alzheimer’s disease. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.